Romain Ohayon - Profile and Investment Details

Find investors who align with your industry, stage, and vision. Unlock Romain Ohayon’s full investment profile, including location, investment focus, portfolio companies, and preferences. Sign up today and start building investor relationships that fuel your startup’s growth.

Get connected with all investors today
img
Country:France
City/Area:

Social media:

Past investments:

  • Genoa Pharmaceuticals
  • ENYO Pharma
  • OncoEthix
  • AM Pharma
  • MedDay
  • HighLife
  • Groupe ADF
  • Groupe JORYF
  • Sogetrel
  • Biogroup-LCD
  • MMI
  • Thomson Video Networks
  • Crescendo Biologics
  • Netco
  • Bacacier group
  • ACE Group
  • Complexa
  • walor
  • Ipside
  • Genkyotex
  • Complix
  • ace credit
  • SANIFIT
  • Atlantic Therapeutics
  • Altavia
  • Verona Pharma
  • Chase Pharmaceuticals
  • Loyalty Company
  • The Bioclinic Group
  • Groupe 3S
  • T-knife
  • Endosense
  • Poxel
  • HR Path
  • Axonics Modulation Technologies
  • La Vie Saine
  • Sfam
  • Mondial Pet Distribution
  • Sirsa
  • ReViral
  • In'Tech Medical
  • Inotrem
  • A2IA
  • Opportunity
  • Artios Pharma
  • GamaMabs Pharma
  • Corvidia
  • Mastergrid
  • Minafin
  • Maesa Group
  • Finsecur
  • orbility
  • Solware Group
  • Exciva
  • Covagen
  • Avalyn Pharma
  • LogicBio Therapeutics
  • erytech
  • Groupe ERGET
  • Atland
  • Medlumics
  • The Reefer Group
  • Studia group
  • Travelsoft
  • REALEASE Capital
  • Rougnon
  • Fortesan
  • La Toulousaine
  • Grey Wolf Therapeutics
  • Globe Groupe
  • Autonomic Technologies
  • Tournus Equipement
  • JenaValve Technology
  • SPHEREA
  • Allecra Therapeutics
  • MS Vacances
  • Passman
  • Emeraude International
  • Dynacure
  • Tricares
  • Pennel & Flipo
  • AgomAb Therapeutics
  • Arvelle Therapeutics

Investor Profile

Romain Ohayon is a Venture Capital, Private Equity Firm based in Paris, Île-de-France, France with a diverse investment portfolio that includes companies such as Genoa Pharmaceuticals, ENYO Pharma, OncoEthix, AM Pharma, MedDay, HighLife, Groupe ADF, Groupe JORYF, Sogetrel, Biogroup-LCD, MMI, Thomson Video Networks, Crescendo Biologics, Netco, Bacacier group, ACE Group, Complexa, walor, Ipside, Genkyotex, Complix, ace credit, SANIFIT, Atlantic Therapeutics, Altavia, Verona Pharma, Chase Pharmaceuticals, Loyalty Company, The Bioclinic Group, Groupe 3S, T-knife, EndosensePoxel, HR Path, Axonics Modulation Technologies, La Vie Saine, Sfam, Mondial Pet Distribution, Sirsa, ReViral, In'Tech Medical, Inotrem, A2IA, Opportunity, Artios Pharma, GamaMabs Pharma, Corvidia, Mastergrid, Minafin, Maesa Group, Finsecur, orbility, Solware Group, Exciva, Covagen, Avalyn Pharma, LogicBio Therapeutics, erytech, Groupe ERGET, Atland, Medlumics, The Reefer Group, Studia group, Travelsoft, REALEASE Capital, Rougnon, Fortesan, La Toulousaine, Grey Wolf Therapeutics, Globe Groupe, Autonomic Technologies, Tournus Equipement, JenaValve Technology, SPHEREA, Allecra Therapeutics, MS Vacances, Passman, Emeraude International, Dynacure, Tricares, Pennel & Flipo, AgomAb Therapeutics, Arvelle Therapeutics, . Over time, Romain Ohayon has demonstrated experience in supporting a range of businesses across various sectors.

While it is not publicly confirmed whether Romain Ohayon is currently seeking new investment opportunities, their past investments provide valuable insight into the types of projects and industries that have attracted their attention.

Startups and entrepreneurs operating in sectors related to Health Care, Wearables, Hospitals, Wellness, Fundraising, Equities, Investment Management, Customer Engagement, Community Development, Energy, Digital Platforms, CRM, Life Science, Robotics, Information Technology (IT), Crowdfunding, Venture Fundraising, Technology, Finance, Biotechnology, Market Research, Consumer Internet, Consulting, Utilities, Social Media, Digital Health, Regulatory Compliance, Renewable Energy, Medical, SaaS, Information Technology, B2B, Therapeutics, Financial Advisory, Health Tech, Pharmaceuticals, Risk Management may find it worthwhile to explore potential connections with Romain Ohayon, as their portfolio suggests a familiarity and interest in this area.

Understanding Romain Ohayon’s investment history can offer useful context for founders considering outreach and help identify whether there is a potential fit based on strategic alignment and market focus.

Finally raise your round with Angel Match

Angel Match is the easiest way to research investors for your startup so you can spend less time Googling and more time raising.

Find the perfect investors today